However, differences in log‐rank tests across other RoMa groups (eg, II versus III, II versus IV or III versus IV) did not reach statistical significance (Figure S1 ).
← all excerpts
RoMa: A Cardiopulmonary Exercise Testing Based Risk Tool in Hypertrophic Cardiomyopathy.
1
—
—